Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity

Oncology

Volumn 80, Issue 1-2, 2011, Pages 107-117

  Hong, Soojung ^a,b   Shin, Sang Joon ^a,b   Jung, Minkyu ^a,b   Jeong, Jaeheon ^a,b   Lee, Young Joo ^a,b   Shin, Kyoo Ho ^b   Roh, Jae Kyung ^a,b   Rha, Sun Young ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Neoadjuvant; Osteosarcoma; Toxicity

Indexed keywords

CISPLATIN; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LACTATE DEHYDROGENASE; MESNA;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; BONE CANCER; BRAIN DISEASE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DRUG FATALITY; DRUG RESPONSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; FEMUR TUMOR; FOLLOW UP; HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPOKALEMIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIMB DISEASE; LIMB SALVAGE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OSTEOSARCOMA; OUTCOME ASSESSMENT; PATHOLOGIC FRACTURE; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SALVAGE THERAPY; SCHOOL CHILD; SEPTIC SHOCK; SIDE EFFECT; SURGICAL PATIENT; THROMBOCYTOPENIA; TUMOR NECROSIS; VOMITING; WOUND COMPLICATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CISPLATIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; OSTEOSARCOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958768908     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000327216     Document Type: Article

References (39)

1. Friedman MA, Carter SK: The therapy of osteogenic sarcoma: Current status and thoughts for the future. J Surg Oncol 1972; 4: 482-510.
2. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314: 1600-1606. (Pubitemid 16118216)
3. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J: Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 1987; 5: 21-26. (Pubitemid 17007852)
4. Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG: Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 1979; 43: 2163-2177. (Pubitemid 9246383)
5. Ferrari S, Palmerini E: Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr Opin Oncol 2007; 19: 341-346. (Pubitemid 46883523)
6. Chou AJ, Gorlick R: Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 2006; 6: 1075-1085. (Pubitemid 44203385)
7. Tunn PU, Reichardt P: Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients. Onkologie 2007; 30: 228-232. (Pubitemid 46674904)
8. van Dalen EC, de Camargo B: Methotrexate for high-grade osteosarcoma in children and young adults. Cochrane Database Syst Rev 2009:CD006325.
9. Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980; 153: 106-120. (Pubitemid 11217753)
10. Pratt CB, Horowitz ME, Meyer WH, Etcubanas E, Thompson EI, Douglass EC, Wilimas JA, Hayes FA, Green AA: Phase II trial of ifosfamide in children with malignant solid tumors. Cancer Treat Rep 1987; 71: 131-135. (Pubitemid 17030141)
11. Goorin AM, Harris MB, Bernstein M, Ferguson W, Devidas M, Siegal GP, Gebhardt MC, Schwartz CL, Link M, Grier HE: Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol 2002; 20: 426-433. (Pubitemid 34072525)
12. Bacci G, Lari S: Current treatment of high grade osteosarcoma of the extremity: review. J Chemother 2001; 13: 235-243. (Pubitemid 32575134)
13. Huvos AG, Rosen G, Marcove RC: Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 1977; 101: 14-18. (Pubitemid 8190735)
14. Ferguson WS, Goorin AM: Current treatment of osteosarcoma. Cancer Invest 2001; 19: 292-315. (Pubitemid 32374371)
15. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221-1230. (Pubitemid 12187826)
16. Bielack S, Carrle D, Jost L: Osteosarcoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19(suppl 2):ii94-ii96.
17. Souhami RL, Craft AW, Van der Eijken JW, Nooij M, Spooner D, Bramwell VH, Wierzbicki R, Malcolm AJ, Kirkpatrick A, Uscinska BM, Van Glabbeke M, Machin D: Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European osteosarcoma intergroup. Lancet 1997; 350: 911-917. (Pubitemid 27420527)
18. Jaffe N, Knapp J, Chuang VP, Wallace S, Ayala A, Murray J, Cangir A, Wang A, Benjamin RS: Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer 1983; 51: 402-407. (Pubitemid 13185366)
19. Hugate RR, Wilkins RM, Kelly CM, Madsen W, Hinshaw I, Camozzi AB: Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults. Clin Orthop Relat Res 2008; 466: 1292-1301.
20. Choi HS, Kang HJ, Lee JA, Han HH, Park HJ, Yoo ES, Kim WS, Shin HY, Kim IO, Lee SH, Ahn HS, Lee HK: Treatment result of pediatric osteosarcoma with intraarterial cisplatin. J Korean Cancer Assoc 1998; 30: 169-177.
21. Jaffe N, Prudich J, Knapp J, Wang YM, Bowman R, Cangir A, Ayala A, Chuang V, Wallace S: Treatment of primary osteosarcoma with intra-arterial and intravenous highdose methotrexate. J Clin Oncol 1983; 1: 428-431. (Pubitemid 13002960)
22. Rha SY, Gong SJ, Chung HC, Shim KY, Ahn JB, Yoo NC, Chung HC, Kim JH, Roh HK, Min JS, Kim BS, Shin KH, Yang WI, Lee CI: The efficacy of pre-operative chemotherapy with intra-arterial cisplatin and intravenous adriamycin for high grade osteosarcoma. J Korean Cancer Assoc 1999; 31: 134-143.
23. Sohn JH, Rha SY, Jeung HC, Shin HJ, Goo YS, Chung HC, Yang WI, Hahn SB, Shin KH, Min JS, Kim BS, Roh JK, Jang WI: Efficacy of pre-and postoperative chemotherapy in patients with osteosarcoma of the extremities. Cancer Res Treat 2001; 33: 520-526.
24. Benjamin RS: Regional chemotherapy for osteosarcoma. Semin Oncol 1989; 16: 323-327. (Pubitemid 19216391)
25. Dirix LY, Van Oosterom AT: The role of ifosfamide in the treatment of sarcomas. Semin Oncol 1989; 16: 39-45. (Pubitemid 19116955)
26. Marti C, Kroner T, Remagen W, Berchtold W, Cserhati M, Varini M: High-dose ifosfamide in advanced osteosarcoma. Cancer Treat Rep 1985; 69: 115-117. (Pubitemid 15197088)
27. Patel SR, Vadhan-Raj S, Papadopolous N, Plager C, Burgess MA, Hays C, Benjamin RS: High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies-dose-response and schedule dependence. J Clin Oncol 1997; 15: 2378-2384. (Pubitemid 27251141)
28. Marina N, Gebhardt M, Teot L, Gorlick R: Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 2004; 9: 422-441. (Pubitemid 39014554)
29. Huvos AG, Rosen G, Bretsky SS, Butler A: Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients. Cancer 1982; 49: 1679-1689. (Pubitemid 12146956)
30. Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C: Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 1993; 72: 3227-3238. (Pubitemid 23356765)
31. Salzer-Kuntschik M, Delling G, Beron G, Sigmund R: Morphological grades of regression in osteosarcoma after polychemotherapy-study COSS 80. J Cancer Res Clin Oncol 1983; 106(suppl):21-24. (Pubitemid 13040817)
32. Kim MS, Lee SY, Lee TR, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG: Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol 2009; 20: 955-960.
33. Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U: Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 1985; 56: 1515-1521. (Pubitemid 15228493)
34. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V: Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 1988; 6: 329-337. (Pubitemid 18065939)
35. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776-790. (Pubitemid 34111386)
36. Ferrari S, Bertoni F, Mercuri M, Picci P, Giacomini S, Longhi A, Bacci G: Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 2001; 12: 1145-1150. (Pubitemid 32834497)
37. Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P: Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 106: 1154-1161.
38. Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW, Taminiau AH: Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007; 99: 112-128.
39. Basaran M, Bavbek ES, Saglam S, Eralp L, Sakar B, Atalar AC, Bilgic B, Ozger H, Onat H: A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Oncology 2007; 72: 255-260. (Pubitemid 351161619)